Page 3 - கால்குட்டா பள்ளி ஆஃப் வெப்பமண்டல மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கால்குட்டா பள்ளி ஆஃப் வெப்பமண்டல மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கால்குட்டா பள்ளி ஆஃப் வெப்பமண்டல மருந்து Today - Breaking & Trending Today

Centre invites medical graduates to join Covid workforce


Centre invites medical graduates to join Covid workforce
The health ministry said it would give the candidates at least one month’s time for study period after the announcement of the examination date
The Centre on Monday invited medical graduates across India studying for the National Eligibility-Cum-Entrance Test for postgraduate (PG) courses to join the Covid-19 workforce, assuring them that the exam will not be held before August 31.
The Union health ministry has asked states to reach out to all such prospective NEET candidates and persuade them to join the Covid-19 workforce and help augment human resources at a time the savage second wave of the pandemic has overwhelmed hospitals and medical staff. ....

West Bengal , Santanu Tripathi , National Eligibility , Centre On , Calcutta School Of Tropical Medicine , National Eligibility Cum Entrance Test , Calcutta School , மேற்கு பெங்கல் , சந்தனு திரிபாதி , தேசிய தகுதி , மையம் ஆன் , கால்குட்டா பள்ளி ஆஃப் வெப்பமண்டல மருந்து , தேசிய தகுதி படகோட்டி நுழைவு சோதனை , கால்குட்டா பள்ளி ,

You can get Covid-19 even after getting two doses of vaccine. But there is no need to panic


You can get Covid-19 even after getting two doses of vaccine. But there is no need to panic
You can get Covid-19 even after getting two doses of vaccine. But there is no need to panic
Several questions have been raised after some reports emerged with claims that people are testing Covid-19 positive even after being administered both doses of a vaccine. But is it, in fact, possible to test positive after getting both the doses of vaccine? What should you do if you test positive? Here are all your questions answered.
advertisement
UPDATED: April 30, 2021 21:33 IST
A medical worker prepares to inoculate a woman with the dose of Covishield vaccine against the Covid-19 coronavirus at a government high school in Hyderabad. (Image for representation: AFP) ....

United Kingdom , West Bengal , Amitabha Nandy , Ganesh Divekar , Ranjan Bhattacharya , Balram Bhargava , Us Centers For Disease , Calcutta School Of Tropical Medicine , Indian Council Of Medical Research , Apollo Hospital , Calcutta School , Indian Council , Medical Research , Bharat Biotech , General Balram Bhargava , Disease Control , ஒன்றுபட்டது கிஂக்டம் , மேற்கு பெங்கல் , அமிதாபா நந்தி , அஞ்சன் பட்டாச்சார்யா , பால்ராம் பார்கவா , எங்களுக்கு மையங்கள் க்கு நோய் , கால்குட்டா பள்ளி ஆஃப் வெப்பமண்டல மருந்து , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , அப்பல்லோ மருத்துவமனை , கால்குட்டா பள்ளி ,

Covid pandemic: Few infections after vaccines


Only three to four persons per 10,000 vaccinated with either Covaxin or Covishield have developed Covid-19 infections after two doses, India’s health research agency said on Wednesday, releasing preliminary results of real-world efficacy.
The Indian Council of Medical Research (ICMCR) said it had counted 695 (0.04 per cent) infections among 1,737,178 people who had received two Covaxin doses and 5,014 (0.03 per cent) infections among 15,732,754 people who had received two Covishield doses.
“These are very small numbers and not at all worrisome,” said Balram Bhargava, the ICMR’s director-general. “We call infections after vaccinations breakthrough infections. The two vaccines we’re using are designed to reduce infections and prevent severe disease and deaths.” ....

West Bengal , Tamil Nadu , Rahul Siddharthan , Manmohan Singh , Santanu Tripathi , Balram Bhargava , Institute Of Mathematical Sciences , Calcutta School Of Tropical Medicine , Indian Council Of Medical Research , Indian Council , Medical Research , Prime Minister Manmohan , Mathematical Sciences , Calcutta School , மேற்கு பெங்கல் , தமிழ் நாடு , ம்யாந்‌மோஹாந் சிங் , சந்தனு திரிபாதி , பால்ராம் பார்கவா , நிறுவனம் ஆஃப் கணித அறிவியல் , கால்குட்டா பள்ளி ஆஃப் வெப்பமண்டல மருந்து , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , இந்தியன் சபை , மருத்துவ ஆராய்ச்சி , ப்ரைம் அமைச்சர் ம்யாந்‌மோஹாந் , கணித அறிவியல் ,

Covid: Emergency nod for foreign jabs - Telegraph India


The Centre on Tuesday waived clinical trial preconditions for emergency use authorisation of Covid-19 vaccines approved by select foreign regulatory agencies, seeking to augment India’s vaccine basket and accelerate the inoculation campaign.
The Union health ministry has accepted the recommendations of an expert panel to expedite emergency use authorisation of vaccines already approved by the US Food and Drug Administration, the European Medicines Agency, the regulatory agencies of Japan and the UK, and those listed by the World Health Organisation.
The move, advocated for weeks by sections of health experts, opens a window of opportunity for companies such as Pfizer, Moderna, and Johnson and Johnson to introduce their vaccines in India without the mandatory local clinical trials, health officials said. ....

United Kingdom , West Bengal , Vinod Paul , Giridhar Babu , Santanu Tripathi , Centre On , Drug Administration , Calcutta School Of Tropical Medicine , Indian Institute Of Public Health , World Health Organisation , European Medicines Agency , Serum Institute Of India , World Health , National Expert Group , Vaccine Administration , Niti Aayog , Serum Institute , Indian Institute , Public Health , Calcutta School , ஒன்றுபட்டது கிஂக்டம் , மேற்கு பெங்கல் , வினோத் பால் , கிரிதர் பாபு , சந்தனு திரிபாதி , மையம் ஆன் ,